TWST — Twist Bioscience Corp

—
Nasdaq · Health Care · Biotechnology · CIK 1581280 ·
Last close
$182.83
Market Cap
$12.12B
52W High
$186.20
52W Low
$23.30
ADV30
1,893,813
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 118,376,000 62,454,000 -36,280,000 -35,051,000 672,437,000 117,436,000 226,698,000
Mar 2026 110,715,000 57,122,000 -38,658,000 -44,021,000 676,214,000 122,670,000 221,120,000
Dec 2025 103,698,000 53,972,000 -33,100,000 -30,507,000 638,085,000 148,591,000 181,990,000
Sep 2025 99,009,000 50,837,000 -29,934,000 -27,138,000 641,861,000 183,049,000 168,903,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-53,072,000
Investing CF
$-45,240,000
Financing CF
$13,797,000
CapEx
$-40,151,000
Dividends Paid
—
Buybacks
$-18,000
EPS Diluted TTM
$-2.22
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,429,157,000
Inventory
$35,162,000
Receivables
$87,581,000
ST Investments
$49,403,000
EBIT TTM
$-137,972,000
Pretax Income TTM
$-135,853,000
Interest Exp TTM
$167,000
Analysts
10

Yahoo Snapshot (yfinance, live)

Total Revenue
$431,798,016
EBITDA
$-115,282,000
Free Cash Flow
$-64,822,500
Enterprise Value
$7,919,389,696
Total Cash
$166,839,008
Total Debt
$108,590,000
Shares Out
66,301,174
Trailing EPS
$-2.22
Book Value
$7.11
ROE
-29.6%
ROA
-13.1%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Sep 2025 376,572,000 -136,259,000 -77,670,000 641,861,000 168,903,000 472,958,000 -47,628,000
Sep 2024 312,974,000 -175,901,000 -208,726,000 614,323,000 141,634,000 472,689,000 -64,094,000
Sep 2023 245,109,000 -206,903,000 -204,618,000 776,403,000 152,971,000 623,432,000 -142,474,000
Sep 2022 203,565,000 -249,021,000 -217,863,000 961,378,000 171,993,000 789,385,000 -124,385,000

TTM Snapshot

Revenues TTM
$174,257,000
NetIncome TTM
$-124,899,000
OpCashFlow TTM
$0
Assets (Latest)
$641,861,000
Forward EPS
$-0.63

Max Pain — expiry 2026-10-16

max pain strike: $145.00 · spot: $181.95 · call oi: 2,558 · put oi: 2,983
Expected Move to 2026-10-16: ±$32.00 (17.59%) — implied range $149.95 – $213.95 · ATM straddle on $180.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
TECH BIO-TECHNE Corp $11.39B $72.61 —
HALO HALOZYME THERAPEUTICS, INC. $12.93B $113.90 —
RGEN REPLIGEN CORP $10.70B $189.68 —
NBIX NEUROCRINE BIOSCIENCES INC $14.07B $138.40 —
KRYS Krystal Biotech, Inc. $10.24B $345.82 —

News headlines (Yahoo Finance, 1h cache)

What Needs To Be True To Buy Twist Bioscience Stock Now?
2026-09-25 22:29 · Yahoo
Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen.
2026-09-25 04:36 · Yahoo
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
2026-09-22 10:08 · Yahoo
Practice Caution with This Hot Stock Up 493% in the Past Year
2026-09-21 15:50 · Yahoo
Why Twist Bioscience Stock Skyrocketed This Week
2026-09-18 23:56 · Yahoo
DNA Synthesis Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Integrated DNA Technologies, GenScript Biotech, and Twist Bioscience
2026-09-18 10:45 · Yahoo
TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short
2026-09-17 21:44 · Yahoo
Twist Bioscience (TWST) Is Up 14.0% After Lilly AI Drug Discovery Tie-Up Is Announced - Has The Bull Case Changed?
2026-09-17 10:10 · Yahoo
AI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST)
2026-09-16 13:59 · Yahoo
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday
2026-09-16 13:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.